SLONKOVA, Jana, Milos CHUDY, Ariunjargal TOGTOKHJARGAL, Hana TOMASKOVA, Hana VACOVSKA, Gisela RYTIROVA and Irena DOLEŽALOVÁ. The effects of COVID-19 on sleep and general health of Czech patients with epilepsy. Heliyon. Oxford: Elsevier, 2023, vol. 9, No 2, p. 1-8. ISSN 2405-8440. Available from: https://dx.doi.org/10.1016/j.heliyon.2023.e13413.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The effects of COVID-19 on sleep and general health of Czech patients with epilepsy
Authors SLONKOVA, Jana (203 Czech Republic), Milos CHUDY (203 Czech Republic), Ariunjargal TOGTOKHJARGAL (203 Czech Republic), Hana TOMASKOVA (203 Czech Republic), Hana VACOVSKA (203 Czech Republic), Gisela RYTIROVA (203 Czech Republic) and Irena DOLEŽALOVÁ (203 Czech Republic, belonging to the institution).
Edition Heliyon, Oxford, Elsevier, 2023, 2405-8440.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.000 in 2022
RIV identification code RIV/00216224:14110/23:00133825
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.heliyon.2023.e13413
UT WoS 000969339100001
Keywords in English COVID-19; sleep; epilepsy
Tags 14110127, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 19/3/2024 09:11.
Abstract
Objectives: To assess the impact of COVID-19 illness and pandemic era on sleep, general health, health care, and social status in patients with epilepsy in the Czech Republic.Methods: Our designed and approved questionnaire consisted of 23 questions. We focused on (1) patients' demographic and epidemiological data regarding COVID-19, (2) subjective assessment of sleep; (3) epilepsy, and (4) perception of general health during the first year of the COVID-19 pandemic in the Czech Republic from March 2020 to May 2021. We administered the questionnaires during outpatient visits or by phone calls in three major university Czech epilepsy centers (Ostrava, Brno, Pilsen).Results: We enrolled 227 (100%) patients. The mean age (+/- SD) was 41.2 +/- 14.82 years (min 18, max 86 years), and 138 (61%) were women. COVID-19 was confirmed using the PCR test method in 57 (25.1%) patients. In the pre-pandemic era, 62 (27.3%) patients reported sleep distur-bances. Insomnia in 46 (74.2%) and excessive daytime sleepiness in 6 (9.7%) were the most mentioned sleep abnormalities. Nocturnal seizures predispose to sleep impairment (p = 0.014) and vivid dreams and nightmares (p = 0.033). COVID-19 infection significantly increased the risk of vivid dreams and nightmares in patients with diurnal seizures (p = 0.006). Sleep quality impairment and seizure frequency worsening [(p < 0.001) and (p = 0.001), respectively] were the most significant risk factors to perform general health deterioration regardless of having COVID-19 (p = 0.559). The most affected age group was 51+ years (p = 0.033). The three centers provided adequate outpatient care during the first year of the pandemic. The employment and social status of the patients remained unchanged (p = 0.074).Conclusions: COVID-19 infection significantly increased the occurrence of vivid dreams and nightmares in patients with diurnal seizures. Sleep quality deterioration and seizure frequency worsening significantly negatively impacted general health performance.
PrintDisplayed: 21/7/2024 08:27